Passive transfer of IgG anti-GM1 antibodies impairs peripheral nerve repair

Journal of Neuroscience

Volumn 30, Issue 28, 2010, Pages 9533-9541

  Lopez, Pablo H ^a,c   Zhang, Gang ^a,b   Zhang, Jiangyang ^a   Lehmann, Helmar C ^a   Griffin, John W ^a   Schnaar, Ronald L ^a   Sheikh, Kazim A ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c INSTITUTO DE INVESTIGACIÓN MÉDICA MERCEDES Y MARTÍN FERREYRA   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN B SUBUNIT; GANGLIOSIDE GM1; GANGLIOSIDE GM1 ANTIBODY; IMMUNOGLOBULIN G; LIGAND; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GUILLAIN BARRE SYNDROME; HUMAN; LIGAND BINDING; MOUSE; NERVE FIBER REGENERATION; NONHUMAN; PASSIVE IMMUNIZATION; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; SENSORY NERVE;

ANALYSIS OF VARIANCE; ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; AUTOANTIBODIES; ELECTROPHYSIOLOGY; GANGLIOSIDES; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MICE; NERVE REGENERATION; PERIPHERAL NERVES;

EID: 77954700015     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2281-10.2010     Document Type: Article

References (64)

1. Alisky JM, van de Wetering CI, Davidson BL (2002) Widespread dispersal of cholera toxin subunit b to brain and spinal cord neurons following systemic delivery. Exp Neurol 178:139-146.
2. Annunziata P, Figura N, Galli R, Mugnaini F, Lenzi C (2003) Association of anti-GM1 antibodies but not of anti-cytomegalovirus, Campylobacter jejuni and Helicobacter pylori IgG, with a poor outcome in Guillain-Barre syndrome. J Neurol Sci 213:55-60.
3. Asbury AK, Arnason BG, Adams RD (1969) The inflammatory lesion in idiopathic polyneuritis. Medicine 48:173-215.
4. Aspinall GO, Fujimoto S, McDonald AG, Pang H, Kurjanczyk LA, Penner JL (1994) Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barre syndrome patients mimic human gangliosides in structure. Infect Immun 62:2122-2125.
5. Bech E, Orntoft TF, Andersen LP, Skinhøj P, Jakobsen J (1997) IgM anti-GM1 antibodies in the Guillain-Barre syndrome: a serological predictor of the clinical course. J Neuroimmunol 72:59-66. (Pubitemid 27016153)
6. Black MM, Lasek RJ (1979) Slowing of the rate of axonal regeneration during growth and maturation. Exp Neurol 63:108-119.
7. Bouchard C, Lacroix C, Planté V, Adams D, Chedru F, Guglielmi JM, Said G (1999) Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 52:498-503. (Pubitemid 29075593)
8. Brown WF, Feasby TE (1984) Conduction block and denervation in Guillain-Barre polyneuropathy. Brain 107:219-239.
9. Buckley NE, Su Y, Milstien S, Spiegel S (1995) The role of calcium influx in cellular proliferation induced by interaction of endogenous ganglioside GM1 with the B subunit of cholera toxin. Biochim Biophys Acta 1256:275-283.
10. Carpo M, Pedotti R, Allaria S, Lolli F, Matà S, Cavaletti G, Protti A, Pomati S, Scarlato G, Nobile-Orazio E (1999) Clinical presentation and outcome of Guillain-Barre and related syndromes in relation to anti-ganglioside antibodies. J Neurol Sci 168:78-84.
11. Cross AH, Trotter JL, Lyons J (2001) B cells and antibodies in CNS demyelinating disease. J Neuroimmunol 112:1-14.
12. Dell A, Reason AJ, Khoo KH, Panico M, McDowell RA, Morris HR (1994) Mass spectrometry of carbohydrate-containing biopolymers. Methods Enzymol 230:108-132.
13. Enders U, Karch H, Toyka KV, Michels M, Zielasek J, Pette M, Heesemann J, Hartung HP (1993) The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barre syndrome and in other neuroimmunological disorders. Ann Neurol 34:136-144.
14. Feasby TE, Gilbert JJ, Brown WF, Bolton CF, Hahn AF, Koopman WF, Zochodne DW (1986) An acute axonal form of Guillain-Barré polyneuropathy. Brain 109:1115-1126.
15. Gong Y, Tagawa Y, Lunn MP, Laroy W, Heffer-Lauc M, Li CY, Griffin JW, Schnaar RL, Sheikh KA (2002) Localization of major gangliosides in the PNS: implications for immune neuropathies. Brain 125:2491-2506. (Pubitemid 35303508)
16. Goodfellow JA, Bowes T, Sheikh K, Odaka M, Halstead SK, Humphreys PD, Wagner ER, Yuki N, Furukawa K, Furukawa K, Plomp JJ, Willison HJ (2005) Overexpression of GD1a ganglioside sensitizes motor nerve terminals to anti-GD1a antibody-mediated injury in a model of acute motor axonal neuropathy. J Neurosci 25:1620-1628. (Pubitemid 40279266)
17. Greenshields KN, Halstead SK, Zitman FM, Rinaldi S, Brennan KM, O'Leary C, Chamberlain LH, Easton A, Roxburgh J, Pediani J, Furukawa K, Furukawa K, Goodyear CS, Plomp JJ, Willison HJ (2009) The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice. J Clin Invest 119:595-610.
18. Gregson NA, Koblar S, Hughes RA (1993) Antibodies to gangliosides in Guillain-Barre syndrome: specificity and relationship to clinical features. Q J Med 86:111-117. (Pubitemid 23125003)
19. Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV (1998) Electrophysiological classification of Guillain-Barre syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Ann Neurol 44:780-788. (Pubitemid 28516049)
20. Hadden RD, Karch H, Hartung HP, Zielasek J, Weissbrich B, Schubert J, Weishaupt A, Cornblath DR, Swan AV, Hughes RA, Toyka KV (2001) Preceding infections, immune factors, and outcome in Guillain-Barre syndrome. Neurology 56:758-765.
21. Hirabayashi Y, Suzuki T, Suzuki Y, Taki T, Matsumoto M, Higashi H, Kato S (1983) A new method for purification of anti-glycosphingolipid antibody-avian anti-hematoside (Neugc) antibody. J Biochem 94:327-330.
22. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, Asbury AK, Blaser MJ, McKhann GM (1995) Guillain-Barre syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118:597-605.
23. Hughes RA, Cornblath DR (2005) Guillain-Barre syndrome. Lancet 366:1653-1666.
24. Ilyas AA, Mithen FA, Dalakas MC, Chen ZW, Cook SD (1992) Antibodies to acidic glycolipids in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 107:111-121.
25. Jacobs BC, van Doorn PA, Schmitz PI, Tio-Gillen AP, Herbrink P, Visser LH, Hooijkass H, van der Meché FG (1996) Campylobacter jejuni infections and anti-GM1 antibodies in Guillain-Barré syndrome. Ann Neurol 40:181-187. (Pubitemid 26274553)
26. Jacobs BC, Hazenberg MP, Van Doorn PA, Endtz HP, van der Meché FGA (1997) Cross-reactive antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in patients with Guillain-Barré or Miller Fisher syndrome. J Infect Dis 175:729-733.
27. Kanter JL, Narayana S, Ho PP, Catz I, Warren KG, Sobel RA, Steinman L, Robinson WH (2006) Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat Med 12:138-143. (Pubitemid 43050089)
28. Koga M, Yuki N, Hirata K, Morimatsu M, Mori M, Kuwabara S (2003) Anti-GM1 antibody IgG subclass: a clinical recovery predictor in Guillain-Barre syndrome. Neurology 60:1514-1518. (Pubitemid 36554815)
29. Kuwabara S, Yuki N, Koga M, Hattori T, Matsuura D, Miyake M, Noda M (1998a) IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barre syndrome. Ann Neurol 44:202-208. (Pubitemid 28374108)
30. Kuwabara S, Asahina M, Koga M, Mori M, Yuki N, Hattori T (1998b) Two patterns of clinical recovery in Guillain-Barre syndrome with IgG anti-GM1 antibody. Neurology 51:1656-1660. (Pubitemid 28565248)
31. Lehmann HC, Lopez PH, Zhang G, Ngyuen T, Zhang J, Kieseier BC, Mori S, Sheikh KA (2007) Passive immunization with anti-ganglioside antibodies directly inhibits axon regeneration in an animal model. J Neurosci 27:27-34. (Pubitemid 46089956)
32. Lopez PH, Irazoqui FJ, Nores GA (2000) Normal human plasma contains antibodies that specifically block neuropathy-associated human anti-GM1 IgG-antibodies. J Neuroimmunol 105:179-183.
33. Lopez PH, Villa AM, Sica RE, Nores GA (2002) High affinity as a disease determinant factor in anti-GM(1) antibodies: comparative characterization of experimentally induced vs disease-associated antibodies. J Neuroimmunol 128:69-76.
34. Lopez PH, Zhang G, Bianchet MA, Schnaar RL, Sheikh KA (2008) Structural requirements of anti-GD1a antibodies determine their target specificity. Brain 131:1926-1939. (Pubitemid 351957448)
35. MacKenzie CR, Hirama T, Lee KK, Altman E, Young NM (1997) Quantitative analysis of bacterial toxin affinity and specificity for glycolipid receptors by surface plasmon resonance. J Biol Chem 272:5533-5538. (Pubitemid 27102376)
36. Nores GA, Hanai N, Levery SB, Eaton HL, Salyan EK, Hakomori S (1988) Synthesis and characterization of lyso-GM3 (II3Neu5Ac Lactosyl sphingosine), de-N-acetyl-GM3 (II3NeuNH2 lactosyl Cer), and related compounds. Carbohydr Res 179:393-410.
37. Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N (2000) Axonal Guillain-Barre syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 48:624-631.
38. O'Hanlon GM, Paterson GJ, Wilson G, Doyle D, McHardie P, Willison HJ (1996) Anti-GM1 ganglioside antibodies cloned from autoimmune neuropathy patients show diverse binding patterns in the rodent nervous system. J Neuropathol Exp Neurol 55:184-195. (Pubitemid 26069296)
39. Press R, Matá S, Lolli F, Zhu J, Andersson T, Link H (2001) Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barre syndrome. J Neurol Sci 190:41-47. (Pubitemid 33713020)
40. Quattrini A, Lorenzetti I, Sciorati C, Corbo M, Previtali SC, Feltri ML, Canal N, Wrabetz L, Nemni R, Clementi E (2001) Human IgM anti-GM1 autoantibodies modulate intracellular calcium homeostasis in neuroblastoma cells. J Neuroimmunol 114:213-219.
41. Sántha P, Jancsó G (2003) Transganglionic transport of choleragenoid by capsaicin-sensitive C-fibre afferents to the substantia gelatinosa of the spinal dorsal horn after peripheral nerve section. Neuroscience 116:621-627.
42. Schnaar RL, Fromholt SE, Gong Y, Vyas AA, Laroy W, Wayman DM, Heffer-Lauc M, Ito H, Ishida H, Kiso M, Griffin JW, Shiekh KA (2002) IgG-class mouse monoclonal antibodies to major brain gangliosides. Anal Biochem 302:276-284.
43. Schön A, Freire E (1989) Thermodynamics of intersubunit interactions in cholera toxin upon binding to the oligosaccharide portion of its cell surface receptor, ganglioside GM1. Biochemistry 28:5019-5024. (Pubitemid 19162747)
44. Schwartz M, Spirman N (1982) Sprouting from chicken-embryo dorsal root-ganglia induced by nerve growth-factor is specifically inhibited by affinity-purified antiganglioside antibodies. Proc Natl Acad Sci U S A 79:6080-6083. (Pubitemid 13249983)
45. Sheikh KA, Zhang G (2010) An update on pathobiologic roles of anti-glycan antibodies in Guillain-Barré syndrome. F1000 Biology Reports 2:21.
46. Sheikh KA, Nachamkin I, Ho TW, Willison HJ, Veitch J, Ung H, Nicholson M, Li CY, Wu HS, Shen BQ, Cornblath DR, Asbury AK, McKhann GM, Griffin JW (1998) Campylobacter jejuni lipopolysaccharides in Guillain-Barre syndrome: molecular mimicry and host susceptibility. Neurology 51:371-378.
47. Sheikh KA, Deerinck TJ, Ellisman MH, Griffin JW (1999a) The distribution of ganglioside-like moieties in peripheral nerves. Brain 122:449-460.
48. Sheikh KA, Sun J, Liu Y, Kawai H, Crawford TO, Proia RL, Griffin JW, Schnaar RL (1999b) Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects. Proc Natl Acad Sci U S A 96:7532-7537. (Pubitemid 29299696)
49. Sheikh KA, Zhang G, Gong Y, Schnaar RL, Griffin JW (2004) An antiganglioside antibody-secreting hybridoma induces neuropathy in mice. Ann Neurol 56:228-239. (Pubitemid 39037918)
50. Sheikh KA, Zhang G, Lehmann HC (2009) Fc gamma receptors on injured Schwann cells facilitate antibody-mediated modulation of axon regeneration. Presented at the Peripheral Nerve Society Meeting, Würzburg, Germany, July 4-8, 2009. J Peripher Nerv Syst 14 [Suppl]:136.
51. Simone IL, Annunziata P, Maimone D, Liguori M, Leante R, Livrea P (1993) Serum and CSF anti-GM1 antibodies in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 114:49-55. (Pubitemid 23025208)
52. Sparrow JR, McGuinness C, Schwartz M, Grafstein B (1984) Antibodies to gangliosides inhibit goldfish optic-nerve regeneration in vivo. J Neurosci Res 12:233-243. (Pubitemid 14023216)
53. Spirman N, Sela BA, Schwartz M (1982) Antiganglioside antibodies inhibit neuritic outgrowth from regenerating goldfish retinal explants. J Neurochem 39:874-877. (Pubitemid 12034985)
54. Spoerri PE, Rapport MM, Mahadik SP, Roisen FJ (1988) Inhibition of conditioned media-mediated neuritogenesis of sensory ganglia by monoclonal antibodies to GM1 ganglioside. Brain Res 469:71-77.
55. Stefansson K, Marton LS, Dieperink ME, Molnar GK, Schlaepfer WW, Helgason CM (1985) Circulating autoantibodies to the 200,000-dalton protein of neurofilaments in the serum of healthy individuals. Science 228:1117-1119. (Pubitemid 15227378)
56. Svennerholm L, Boström K, Fredman P, Jungbjer B, Månsson JE, Rynmark BM (1992) Membrane lipids of human peripheral nerve and spinal cord. Biochim Biophys Acta 1128:1-7.
57. Tong YG, Wang HF, Ju G, Grant G, Hökfelt T, Zhang X (1999) Increased uptake and transport of cholera toxin B-subunit in dorsal root ganglion neurons after peripheral axotomy: possible implications for sensory sprouting. J Comp Neurol 404:143-158. (Pubitemid 29086541)
58. Toyka KV, Drachman DB, Griffin DE, Pestronk A, Winkelstein JA, Fishbeck KH, Kao I (1977) Myasthenia gravis: study of humoral immune mechanisms by transfer to mice. N Engl J Med 296:125-131. (Pubitemid 8066391)
59. Vriesendorp FJ, Triggs WJ, Mayer RF, Koski CL (1995) Electrophysiological studies in Guillain-Barré syndrome: correlation with antibodies to GM1, GD1B and Campylobacter jejuni. J Neurol 242:460-465.
60. Wang J, Lu ZH, Gabius HJ, Rohowsky-Kochan C, Ledeen RW, Wu G (2009) Cross-linking of GM1 ganglioside by galectin-1 mediates regulatory T cell activity involving TRPC5 channel activation: possible role in suppressing experimental autoimmune encephalomyelitis. J Immunol 182:4036-4045.
61. Willison HJ, Yuki N (2002) Peripheral neuropathies and anti-glycolipid antibodies. Brain 125:2591-2625.
62. Yuki N, Yoshino H, Sato S, Miyatake T (1990) Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis. Neurology 40:1900-1902.
63. Yuki N, Handa S, Taki T, Kasama T, Takahashi M, Saito K (1992) Cross-reactive antigen between nervous tissue and a bacterium elicits Guillain-Barre syndrome: molecular mimicry between gangliocide GM1 and lipopolysaccharide from Penner's serotype 19 of Campylobacter jejuni. Biomed Res 13:451-453. (Pubitemid 23072771)
64. Zhang J, Zhang G, Morrison B, Mori S, Sheikh KA (2008) Magnetic resonance imaging of mouse skeletal muscle to measure denervation atrophy. Exp Neurol 212:448-457.